CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $592,000 | +13.0% | 23,895 | +14.2% | 0.00% | 0.0% |
| Q1 2022 | $524,000 | -31.2% | 20,918 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $762,000 | +115.9% | 20,918 | +1.3% | 0.00% | 0.0% |
| Q3 2021 | $353,000 | +27.9% | 20,645 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $276,000 | -75.4% | 20,645 | -5.7% | 0.00% | -50.0% |
| Q1 2021 | $1,121,000 | -16.7% | 21,882 | +0.7% | 0.00% | -33.3% |
| Q4 2020 | $1,346,000 | +48.4% | 21,736 | +31.3% | 0.00% | +50.0% |
| Q3 2020 | $907,000 | +2.4% | 16,560 | +7.6% | 0.00% | 0.0% |
| Q2 2020 | $886,000 | +8.2% | 15,392 | -24.5% | 0.00% | 0.0% |
| Q1 2020 | $819,000 | +3.7% | 20,378 | +2.0% | 0.00% | 0.0% |
| Q4 2019 | $790,000 | +690.0% | 19,975 | +35.9% | 0.00% | – |
| Q3 2019 | $100,000 | -27.0% | 14,696 | 0.0% | 0.00% | – |
| Q2 2019 | $137,000 | -6.8% | 14,696 | +38.8% | 0.00% | – |
| Q1 2019 | $147,000 | +26.7% | 10,588 | 0.0% | 0.00% | – |
| Q4 2018 | $116,000 | -13.4% | 10,588 | 0.0% | 0.00% | – |
| Q3 2018 | $134,000 | -3.6% | 10,588 | 0.0% | 0.00% | – |
| Q2 2018 | $139,000 | -16.8% | 10,588 | -13.8% | 0.00% | – |
| Q1 2018 | $167,000 | +75.8% | 12,285 | -23.1% | 0.00% | – |
| Q4 2017 | $95,000 | -20.2% | 15,984 | 0.0% | 0.00% | – |
| Q3 2017 | $119,000 | -20.7% | 15,984 | 0.0% | 0.00% | – |
| Q2 2017 | $150,000 | +57.9% | 15,984 | +22.8% | 0.00% | – |
| Q1 2017 | $95,000 | -1.0% | 13,019 | 0.0% | 0.00% | – |
| Q4 2016 | $96,000 | +21.5% | 13,019 | 0.0% | 0.00% | – |
| Q3 2016 | $79,000 | +36.2% | 13,019 | 0.0% | 0.00% | – |
| Q2 2016 | $58,000 | +81.2% | 13,019 | 0.0% | 0.00% | – |
| Q1 2016 | $32,000 | -69.5% | 13,019 | 0.0% | 0.00% | – |
| Q4 2015 | $105,000 | +32.9% | 13,019 | 0.0% | 0.00% | – |
| Q3 2015 | $79,000 | -26.2% | 13,019 | 0.0% | 0.00% | – |
| Q2 2015 | $107,000 | +7.0% | 13,019 | -27.8% | 0.00% | – |
| Q3 2013 | $100,000 | -60.6% | 18,040 | 0.0% | 0.00% | -100.0% |
| Q2 2013 | $254,000 | – | 18,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 436,300 | $15,886,000 | 6.25% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,205,000 | 3.66% |
| Integral Health Asset Management, LLC | 200,000 | $7,282,000 | 2.02% |
| Sofinnova Investments, Inc. | 731,222 | $26,624,000 | 1.56% |
| Lisanti Capital Growth, LLC | 231,035 | $8,412,000 | 1.22% |
| Darwin Global Management, Ltd. | 161,802 | $5,891,000 | 0.90% |
| Cormorant Asset Management, LP | 400,000 | $14,564,000 | 0.87% |
| Perceptive Advisors | 2,830,892 | $103,072,000 | 0.80% |
| Avidity Partners Management LP | 644,400 | $23,463,000 | 0.50% |
| Eventide Asset Management | 1,040,000 | $37,866,000 | 0.48% |